ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Bioheng Announced Oral Presentation of Its Preliminary Results of CRISPR-Engineered Allogeneic CAR-T for r/r B-ALL Treatment at 2020 ASH Meeting
November 13, 2020Bioheng Biotech Co., Ltd, a clinical-stage biotechnology company focuses on developing novel cellular immunotherapy, announced that their preliminary data including the pre-clinical development, manufacturing, and investigator initiated trial (IIT) ...
Pharma Sources Insight January 2025
